Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019 provides an overview of Transmucosal Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transmucosal Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transmucosal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transmucosal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transmucosal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


  • Introduction
    • Transmucosal Drug Delivery Devices Overview
  • Products under Development
    • Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
      • Table Figure 1: Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
      • Table Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
    • Transmucosal Drug Delivery Devices - Pipeline Products by Segment
      • Table Figure 2: Transmucosal Drug Delivery Devices - Pipeline Products by Segment
      • Table Transmucosal Drug Delivery Devices - Pipeline Products by Segment
    • Transmucosal Drug Delivery Devices - Pipeline Products by Territory
      • Table Figure 3: Transmucosal Drug Delivery Devices - Pipeline Products by Territory
      • Table Transmucosal Drug Delivery Devices - Pipeline Products by Territory
    • Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
      • Table Figure 4: Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
      • Table Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
    • Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
      • Table Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
    • Transmucosal Drug Delivery Devices - Ongoing Clinical Trials
      • Table Figure 6: Transmucosal Drug Delivery Devices - Ongoing Clinical Trials
      • Table Transmucosal Drug Delivery Devices - Ongoing Clinical Trials
  • Transmucosal Drug Delivery Devices - Pipeline Products under Development by Companies
    • Transmucosal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
      • Table Transmucosal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
    • Transmucosal Drug Delivery Devices - Companies Pipeline Products by Stage of Development
      • Table Transmucosal Drug Delivery Devices - Companies Pipeline Products by Stage of Development
  • Transmucosal Drug Delivery Devices Companies and Product Overview
    • AcelRx Pharmaceuticals Inc Company Overview
      • AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARX-02 Sufentanil NanoTab BTP Management System - Product Status
        • Table ARX-02 Sufentanil NanoTab BTP Management System - Product Description
        • Table ARX-03 Sufentanil/Trazolam NanoTab - Product Status
        • Table ARX-03 Sufentanil/Trazolam NanoTab - Product Description
        • Table ZALVISO - Product Status
        • Table ZALVISO - Product Description
        • Table AcelRx Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table ZALVISO - Treatment of Acute Post-operative Pain in Patients Undergoing Laparoscopic Colon Resections
        • Table ZALVISO - Usability and Satisfaction Evaluation of Sufentanil Sublingual Patient-controlled Analgesia after Elective Surgery with Moderate-to-severe Postoperative Pain
    • Aegis Therapeutics LLC Company Overview
      • Aegis Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aegis Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table VALTOCO Nasal Spray - Product Status
        • Table VALTOCO Nasal Spray - Product Description
        • Table Aegis Therapeutics LLC - Ongoing Clinical Trials Overview
        • Table VALTOCO Nasal Spray - A 12-month Open-label, Repeat-dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)
        • Table VALTOCO Nasal Spray - An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
    • AFYX Therapeutics A/S Company Overview
      • AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rivelin Combo Patch - Product Status
        • Table Rivelin Combo Patch - Product Description
        • Table AFYX Therapeutics A/S - Ongoing Clinical Trials Overview
        • Table Rivelin Combo Patch - A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate When Administered Intraorally Twice Daily in Patients with Oral Lichen Planus (OLP) Using Rivelin-CLO Patches
    • Albert Einstein College of Medicine Company Overview
      • Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug-Impregnated Intravaginal Ring - Product Status
        • Table Drug-Impregnated Intravaginal Ring - Product Description
    • Allergan Plc Company Overview
      • Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vaginal Ring Contraceptive - Product Status
        • Table Vaginal Ring Contraceptive - Product Description
    • Amphastar Pharmaceuticals Inc Company Overview
      • Amphastar Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amphastar Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intranasal Naloxone Spray - Product Status
        • Table Intranasal Naloxone Spray - Product Description
    • Aquestive Therapeutics Inc Company Overview
      • Aquestive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aquestive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table APL-130277 Sublingual Soluble Film - Product Status
        • Table APL-130277 Sublingual Soluble Film - Product Description
        • Table AQST-108 Sublingual Soluble Film - Product Status
        • Table AQST-108 Sublingual Soluble Film - Product Description
        • Table AQST-119 Oral Soluble Film - Product Status
        • Table AQST-119 Oral Soluble Film - Product Description
        • Table AQST-305 Buccal Soluble Film - Product Status
        • Table AQST-305 Buccal Soluble Film - Product Description
        • Table Diazepam (Libervant) Buccal Film - Product Status
        • Table Diazepam (Libervant) Buccal Film - Product Description
        • Table Exservan - Product Status
        • Table Exservan - Product Description
        • Table Aquestive Therapeutics Inc - Ongoing Clinical Trials Overview
        • Table Diazepam (Libervant) Buccal Film - A Multicenter, Open Label Crossover Study to Assess the
    • ARS Pharmaceuticals Inc Company Overview
      • ARS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARS-1 - Product Status
        • Table ARS-1 - Product Description
    • Auritec Pharmaceuticals Inc Company Overview
      • Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Versa Intravaginal Ring - Acromegaly - Product Status
        • Table Versa Intravaginal Ring - Acromegaly - Product Description
        • Table Versa Intravaginal Ring - Alzheimer's Disease - Product Status
        • Table Versa Intravaginal Ring - Alzheimer's Disease - Product Description
        • Table Versa Intravaginal Ring - Breast Cancer - Product Status
        • Table Versa Intravaginal Ring - Breast Cancer - Product Description
        • Table Versa Intravaginal Ring - Endometriosis - Product Status
        • Table Versa Intravaginal Ring - Endometriosis - Product Description
        • Table Versa Intravaginal Ring - Herpes - Product Status
        • Table Versa Intravaginal Ring - Herpes - Product Description
        • Table Versa Intravaginal Ring - HIV Prophylaxis - Product Status
        • Table Versa Intravaginal Ring - HIV Prophylaxis - Product Description
        • Table Versa Intravaginal Ring - Pain and Addiction - Product Status
        • Table Versa Intravaginal Ring - Pain and Addiction - Product Description
        • Table Versa Intravaginal Ring - Parkinson's Disease - Product Status
        • Table Versa Intravaginal Ring - Parkinson's Disease - Product Description
        • Table Versa Intravaginal Ring - Type II Diabetes - Product Status
        • Table Versa Intravaginal Ring - Type II Diabetes - Product Description
        • Table Versa Intravaginal Ring - Uterine Fibroids - Product Status
        • Table Versa Intravaginal Ring - Uterine Fibroids - Product Description
    • BeFree! Company Overview
      • BeFree! Pipeline Products & Ongoing Clinical Trials Overview
        • Table BeFree! Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vaginal Drug Delivery System - Product Status
        • Table Vaginal Drug Delivery System - Product Description
    • Bespak Europe Ltd Company Overview
      • Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NAS010 - Product Status
        • Table NAS010 - Product Description
        • Table NAS020 - Unidose Nasal Drug Delivery Device - Product Status
        • Table NAS020 - Unidose Nasal Drug Delivery Device - Product Description
        • Table NAS030 Nasal Device - Product Status
        • Table NAS030 Nasal Device - Product Description
    • Biorings LLC Company Overview
      • Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vaginal Ring - Product Status
        • Table Vaginal Ring - Product Description
    • BioXcel Therapeutics Inc Company Overview
      • BioXcel Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioXcel Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BXCL501 Sublingual film - Product Status
        • Table BXCL501 Sublingual film - Product Description
        • Table BioXcel Therapeutics Inc - Ongoing Clinical Trials Overview
        • Table BXCL501 Sublingual film - A Phase 1 Study to Evaluate Pharmacokinetic and Safety of BXCL501 Sublingual film in Healthy Volunteers
    • Callitas Therapeutics Inc Company Overview
      • Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CannaMint Strips - Product Status
        • Table CannaMint Strips - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Focused Ultrasound - Intranasal Drug Delivery - Product Status
        • Table Focused Ultrasound - Intranasal Drug Delivery - Product Description
    • Combinent BioMedical Systems Inc Company Overview
      • Combinent BioMedical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Combinent BioMedical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multi-Segmented Vaginal Ring - Product Status
        • Table Multi-Segmented Vaginal Ring - Product Description
    • Conrad Company Overview
      • Conrad Pipeline Products & Ongoing Clinical Trials Overview
        • Table Conrad Pipeline Products & Ongoing Clinical Trials Overview
        • Table Triple Protection Vaginal Ring - Product Status
        • Table Triple Protection Vaginal Ring - Product Description
        • Table Vaginal Ring - HIV Protection - Product Status
        • Table Vaginal Ring - HIV Protection - Product Description
        • Table Conrad - Ongoing Clinical Trials Overview
        • Table Triple Protection Vaginal Ring - Phase I, 90-day Safety, Pharmacokinetic, and Pharmacodynamic Study of Intravaginal Rings Releasing Tenofovir and Levonorgestrel
    • Dare Bioscience Inc Company Overview
      • Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DARE-FRT1 Intravaginal Ring - Product Status
        • Table DARE-FRT1 Intravaginal Ring - Product Description
        • Table DARE-HRT1 Intravaginal Ring - Product Status
        • Table DARE-HRT1 Intravaginal Ring - Product Description
        • Table DARE-OAB1 - Product Status
        • Table DARE-OAB1 - Product Description
        • Table Ovaprene - Product Status
        • Table Ovaprene - Product Description
        • Table Dare Bioscience Inc - Ongoing Clinical Trials Overview
        • Table Ovaprene - Safety and Acceptability Study of a Non-Hormonal Ring
        • Table DARE-OAB1 - A Phase I Clinical Study of JNP-0201
        • Table DARE-OAB1 - A Phase I Clinical Study of JNP-0301
        • Table DARE-OAB1 - Phase IIa Study of JNP-0101
        • Table DARE-OAB1 - Phase III Study of JNP-0101
    • Emergent BioSolutions Inc Company Overview
      • Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intranasal SIAN Device - Product Status
        • Table Intranasal SIAN Device - Product Description
    • Evestra Inc Company Overview
      • Evestra Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Evestra Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EVE112 - Vaginal Ring - Product Status
        • Table EVE112 - Vaginal Ring - Product Description
        • Table EVE116 - Product Status
        • Table EVE116 - Product Description
        • Table EVE120 Vaginal Ring - Product Status
        • Table EVE120 Vaginal Ring - Product Description
        • Table EVE122 Vaginal Ring - Product Status
        • Table EVE122 Vaginal Ring - Product Description
        • Table Progestin Vaginal Ring - Product Status
        • Table Progestin Vaginal Ring - Product Description
        • Table Vaginal Ring For Preterm Labor - Product Status
        • Table Vaginal Ring For Preterm Labor - Product Description
    • Evofem Biosciences Inc Company Overview
      • Evofem Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Evofem Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nestorone/Ethinyl estradiol (NES/EE) Contraceptive Vaginal Ring (CVR) - Product Status
        • Table Nestorone/Ethinyl estradiol (NES/EE) Contraceptive Vaginal Ring (CVR) - Product Description
    • Evoke Pharma Inc Company Overview
      • Evoke Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Evoke Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gimoti Nasal Spray - Product Status
        • Table Gimoti Nasal Spray - Product Description
    • EyeGate Pharmaceuticals Inc Company Overview
      • EyeGate Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeGate Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeGate II Delivery System - Product Status
        • Table EyeGate II Delivery System - Product Description
    • Ferring Pharmaceuticals AS Company Overview
      • Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table C-Vad Vaginal Insert - Product Status
        • Table C-Vad Vaginal Insert - Product Description
        • Table Premis Vaginal Insert - Product Status
        • Table Premis Vaginal Insert - Product Description
    • Ghent University Company Overview
      • Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Controlled-Release System - Intra-Vaginal Delivery - Product Status
        • Table Controlled-Release System - Intra-Vaginal Delivery - Product Description
    • Glenmark Pharmaceuticals Ltd Company Overview
      • Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ryaltris Nasal Spray - Product Status
        • Table Ryaltris Nasal Spray - Product Description
    • Hebrew University of Jerusalem Company Overview
      • Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
        • Table Buccal Drug Delivery Device - Oral Cavity Disorders - Product Status
        • Table Buccal Drug Delivery Device - Oral Cavity Disorders - Product Description
    • INSYS Therapeutics Inc Company Overview
      • INSYS Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table INSYS Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Buprenorphine/Naloxone Sublingual Spray - Product Status
        • Table Buprenorphine/Naloxone Sublingual Spray - Product Description
        • Table Epinephrine Nasal Spray - Product Status
        • Table Epinephrine Nasal Spray - Product Description
        • Table Naloxone Nasal Spray - Product Status
        • Table Naloxone Nasal Spray - Product Description
        • Table INSYS Therapeutics Inc - Ongoing Clinical Trials Overview
        • Table Epinephrine Nasal Spray - Proof-of-concept Study Evaluating the Bioequivalence of Epinephrine
    • IntelGenx Corp Company Overview
      • IntelGenx Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table IntelGenx Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Montelukast VersaFilm - Product Status
        • Table Montelukast VersaFilm - Product Description
        • Table IntelGenx Corp - Ongoing Clinical Trials Overview
        • Table Montelukast VersaFilm - A Randomized Phase IIa, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety, Feasibility, Tolerability, and Efficacy of a New Buccal Film of Montelukast in Patients with Mild to Moderate Alzheimer's Disease
    • Janssen Research & Development LLC Company Overview
      • Janssen Research & Development LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Janssen Research & Development LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SPRAVATO (Esketamine) CIII Nasal Spray - Product Status
        • Table SPRAVATO (Esketamine) CIII Nasal Spray - Product Description
    • Karessa Pharma AB Company Overview
      • Karessa Pharma AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Karessa Pharma AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table K-01 - Product Status
        • Table K-01 - Product Description
        • Table K-02 - Product Status
        • Table K-02 - Product Description
        • Table K-03 - Product Status
        • Table K-03 - Product Description
        • Table K-21 - Product Status
        • Table K-21 - Product Description
    • Kytogenics Pharmaceuticals Inc Company Overview
      • Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Device - Intestinal Cystitis - Product Status
        • Table Drug Delivery Device - Intestinal Cystitis - Product Description
    • Laboratoire HRA Pharma SAS Company Overview
      • Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table UPA-CVR - Product Status
        • Table UPA-CVR - Product Description
    • Laboratorios Andromaco Company Overview
      • Laboratorios Andromaco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Laboratorios Andromaco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Progering - Product Status
        • Table Progering - Product Description
    • Lyra Therapeutics Company Overview
      • Lyra Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lyra Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
        • Table LYR-210 Transmucosal Delivery System - Product Status
        • Table LYR-210 Transmucosal Delivery System - Product Description
    • McNeil AB Company Overview
      • McNeil AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table McNeil AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antiviral Polymeric Nasal Spray - Product Status
        • Table Antiviral Polymeric Nasal Spray - Product Description
    • Medlab Clinical Ltd Company Overview
      • Medlab Clinical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medlab Clinical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanaBis - Product Status
        • Table NanaBis - Product Description
    • Merck & Co Inc Company Overview
      • Merck & Co Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Merck & Co Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ENG-CVR - Product Status
        • Table ENG-CVR - Product Description
        • Table Nasonex - OTC - Product Status
        • Table Nasonex - OTC - Product Description
        • Table NOMAC-CVR - Product Status
        • Table NOMAC-CVR - Product Description
    • Merck Serono SA Company Overview
      • Merck Serono SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Merck Serono SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table MK-8342 Medicated IUS - Product Status
        • Table MK-8342 Medicated IUS - Product Description
    • Merck Sharp & Dohme Ltd Company Overview
      • Merck Sharp & Dohme Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Merck Sharp & Dohme Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Etonogestrel + 17ß-Estradiol Vaginal Ring - Product Status
        • Table Etonogestrel + 17ß-Estradiol Vaginal Ring - Product Description
    • Mithra Pharmaceuticals SA Company Overview
      • Mithra Pharmaceuticals SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mithra Pharmaceuticals SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Myring - Product Status
        • Table Myring - Product Description
    • Mystic Pharmaceuticals Inc Company Overview
      • Mystic Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mystic Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MystiFen - Product Status
        • Table MystiFen - Product Description
        • Table MystiZof - Product Status
        • Table MystiZof - Product Description
    • Nanosys Inc Company Overview
      • Nanosys Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanosys Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gecko-Inspired Drug Delivery Device - Product Status
        • Table Gecko-Inspired Drug Delivery Device - Product Description
    • NorInvent AB Company Overview
      • NorInvent AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table NorInvent AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table XtriG Drug Delivery Device - Product Status
        • Table XtriG Drug Delivery Device - Product Description
    • Novus Therapeutics Inc Company Overview
      • Novus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OP-02 - Product Status
        • Table OP-02 - Product Description
        • Table Novus Therapeutics Inc - Ongoing Clinical Trials Overview
        • Table OP-02 - A Study to Assess the Safety, Tolerability and Efficacy of Op0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months
        • Table OP-02 - A Study to Assess the Safety, Tolerability and Efficacy of OP0201 in Healthy Subjects
    • Oak Crest Institute of Science Company Overview
      • Oak Crest Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oak Crest Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table pod-IVR - Product Status
        • Table pod-IVR - Product Description
    • Opiant Pharmaceuticals Inc Company Overview
      • Opiant Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Opiant Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NARCAN Nasal Spray - Product Status
        • Table NARCAN Nasal Spray - Product Description
        • Table OPNT001 Opioid Antagonist Nasal Spray - Product Status
        • Table OPNT001 Opioid Antagonist Nasal Spray - Product Description
        • Table OPNT002 Opioid Antagonist Nasal Spray - Product Status
        • Table OPNT002 Opioid Antagonist Nasal Spray - Product Description
        • Table OPNT003 Nasal Spray - Product Status
        • Table OPNT003 Nasal Spray - Product Description
        • Table Opiant Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table NARCAN Nasal Spray - Phase II Clinical Study of Naloxone in Bulimia Nervosa Subjects
        • Table NARCAN Nasal Spray - Phase II Study of Naloxone Hydrochloride in Subjects with Binge Eating
    • OptiNose AS Company Overview
      • OptiNose AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table OptiNose AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table OptiNose Bi-Directional Breath Powered Orexin-A Delivery Device - Product Status
        • Table OptiNose Bi-Directional Breath Powered Orexin-A Delivery Device - Product Description
        • Table XHANCE - Product Status
        • Table XHANCE - Product Description
        • Table OptiNose AS - Ongoing Clinical Trials Overview
        • Table XHANCE - 16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 ìg Twice a Day in Adolescents with Bilateral Nasal Polyps Followed with 12-Week Open-label Treatment Phase
        • Table XHANCE - Evaluate the Safety and Efficacy of XHANCE (Fluticasone Propionate) Nasal Spray as a Treatment for Patients with Chronic Sinusitis
    • Orion Biotechnology Canada Ltd Company Overview
      • Orion Biotechnology Canada Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion Biotechnology Canada Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table OB-002 IVR - Product Status
        • Table OB-002 IVR - Product Description
    • Orphanse Healthcare SAS Company Overview
      • Orphanse Healthcare SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orphanse Healthcare SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table ORH01 Drug Delivery Device - Product Status
        • Table ORH01 Drug Delivery Device - Product Description
    • Palette Life Sciences AB Company Overview
      • Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table SHACT - Product Status
        • Table SHACT - Product Description
    • Phoenix Life Sciences International Ltd Company Overview
      • Phoenix Life Sciences International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phoenix Life Sciences International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phoenix Neuro - Product Status
        • Table Phoenix Neuro - Product Description
        • Table Phoenix Pain - Product Status
        • Table Phoenix Pain - Product Description
        • Table PHOENIX Sport Plus - Product Status
        • Table PHOENIX Sport Plus - Product Description
    • Privo Technologies LLC Company Overview
      • Privo Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Privo Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table PRV111 Patch - Product Status
        • Table PRV111 Patch - Product Description
    • Promius Pharma LLC Company Overview
      • Promius Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Promius Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table TOSYMRA - Product Status
        • Table TOSYMRA - Product Description
    • RDD Pharma Ltd Company Overview
      • RDD Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table RDD Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Capository - Product Status
        • Table Capository - Product Description
    • Renown Pharma Ltd Company Overview
      • Renown Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renown Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sub-Lingual Apomorphine Spray - Product Status
        • Table Sub-Lingual Apomorphine Spray - Product Description
    • Rhinomed Ltd Company Overview
      • Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intranasal Drug Delivery Device - Acute Migraine - Product Status
        • Table Intranasal Drug Delivery Device - Acute Migraine - Product Description
    • Scientus Pharma Inc Company Overview
      • Scientus Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scientus Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RapidMist Buccal Delivery System - Product Status
        • Table RapidMist Buccal Delivery System - Product Description
    • Shenox Pharmaceuticals LLC Company Overview
      • Shenox Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shenox Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SHX-004 - Product Status
        • Table SHX-004 - Product Description
        • Table SHX-005 - Product Status
        • Table SHX-005 - Product Description
        • Table SHX-006 - Product Status
        • Table SHX-006 - Product Description
        • Table SHX-007 - Product Status
        • Table SHX-007 - Product Description
        • Table SHX-008 - Product Status
        • Table SHX-008 - Product Description
        • Table SHX-011 - Product Status
        • Table SHX-011 - Product Description
    • Shin Nippon Biomedical Laboratories Ltd Company Overview
      • Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ìco System - Product Status
        • Table ìco System - Product Description
    • Suda Pharmaceuticals Ltd Company Overview
      • Suda Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Suda Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ArTiMist - Product Status
        • Table ArTiMist - Product Description
        • Table ZolpiMist - Product Description
        • Table ZolpiMist - Product Status
    • Texas Tech University Company Overview
      • Texas Tech University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Texas Tech University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Minimally-Invasive Intratumoral Drug Delivery Needle - Product Status
        • Table Minimally-Invasive Intratumoral Drug Delivery Needle - Product Description
    • The Hong Kong University of Science and Technology Company Overview
      • The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical
        • Table The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Retinal Drug Delivery Device - Product Status
        • Table Retinal Drug Delivery Device - Product Description
    • Therakind Ltd Company Overview
      • Therakind Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therakind Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Reusable Intranasal Device - Product Status
        • Table Reusable Intranasal Device - Product Description
    • TherapeuticsMD Inc Company Overview
      • TherapeuticsMD Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TherapeuticsMD Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ANNOVERA - Product Status
        • Table ANNOVERA - Product Description
    • Tiziana Life Sciences PLC Company Overview
      • Tiziana Life Sciences PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tiziana Life Sciences PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nasal Drug Delivery Device - Product Status
        • Table Nasal Drug Delivery Device - Product Description
    • UCB SA Company Overview
      • UCB SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table UCB SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Midazolam Nasal Spray - Product Status
        • Table Midazolam Nasal Spray - Product Description
    • University of North Carolina at Chapel Hill Company Overview
      • University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3D Printed Intravaginal Rings - Product Status
        • Table 3D Printed Intravaginal Rings - Product Description
    • University of Pittsburgh Company Overview
      • University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table HerShield - Product Status
        • Table HerShield - Product Description
    • University of South Florida Company Overview
      • University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Device - Ovarian Cancer - Product Status
        • Table Drug Delivery Device - Ovarian Cancer - Product Description
    • University of Texas at Austin Company Overview
      • University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transmucosal Patch - Product Status
        • Table Transmucosal Patch - Product Description
    • University of the Witwatersrand Company Overview
      • University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vagitab - Product Status
        • Table Vagitab - Product Description
    • University of Washington Company Overview
      • University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery System - Contraception/HIV-1 infection - Product Status
        • Table Drug Delivery System - Contraception/HIV-1 infection - Product Description
    • Washington University in St Louis Company Overview
      • Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
        • Table Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
        • Table FUSIN Device - Product Status
        • Table FUSIN Device - Product Description
  • Transmucosal Drug Delivery Devices - Recent Developments
    • Apr 30, 2019: Aptar reports first quarter results
    • Apr 30, 2019: In 2018, Marinomed set the course for accelerated growth
    • Apr 08, 2019: Opiant Pharmaceuticals announces publication of clinical pharmacokinetic data supporting potential of OPNT003, nasal nalmefene, for treatment of synthetic opioid overdose
    • Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors
    • Apr 04, 2019: IntelGenx Presents at 14th International Conference on Alzheimer's and Parkinson's Disease
    • Mar 29, 2019: World-renowned scientist, described as the edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Dare Bioscience scientific advisory board
    • Mar 25, 2019: INSYS Therapeutics to present poster of pharmacokinetic study of Naloxone novel nasal spray at The College on Problems of Drug Dependence Annual Scientific Meeting
    • Mar 25, 2019: TherapeuticsMD announces oral and poster presentations on ANNOVERA at the Endocrine Society 2019 Annual Meeting
    • Mar 21, 2019: Aptar Pharma to showcase new market innovations at Interphex 2019, New York City
    • Mar 20, 2019: Superior Psychiatric Services announces new services and products for Depression treatment
    • Mar 19, 2019: VA to make new nasal spray drug available for treatment-resistant depression
    • Mar 18, 2019: Dare Bioscience announces presentations at the 31st Annual ROTH Conference
    • Mar 18, 2019: Aptar Pharma's bidose nasal drug delivery device approved by U.S. FDA for breakthrough treatment of depression
    • Mar 18, 2019: RDD Pharma names John Temperato as Chief Executive Officer
    • Mar 14, 2019: Psychiatrist Keith Ablow, MD Calls On FDA To Approve Generic Ketamine Nasal Spray And Ketamine Intravenous Therapy For Combat Veterans
    • Mar 14, 2019: New FDA-approved nasal spray anti-depressant SPRAVATO now available in Bay Area at Palo Alto Mind Body
    • Mar 14, 2019: BioDelivery Sciences reports strong 2018 results and 2019 expectations
    • Mar 12, 2019: Cogstate computerised tests utilised as part of the overall evaluation of Spravato, which was granted FDA approval for treatment resistant depression
    • Mar 12, 2019: Ketamine-based nasal spray to treat depression
    • Mar 12, 2019: Orion Biotechnology Canada announces three new appointments to their senior management team
    • Mar 12, 2019: Generex Biotechnology appoints new Chief Commercial Officer
    • Mar 12, 2019: Sonoma Pharmaceuticals announces substantial cost-cutting measures
    • Mar 11, 2019: Daré Bioscience receives notification of second award from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the development of Ovaprene
    • Mar 07, 2019: AcelRx Pharmaceuticals Announces Commercial Launch of DSUVIA
    • Mar 07, 2019: AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
    • Mar 05, 2019: Janssen announces U.S. FDA approval of SPRAVATO (esketamine) CIII Nasal Spray for adults with treatment-resistant depression (TRD) who have cycled through multiple treatments without relief
    • Mar 04, 2019: Evoke Pharma Receives Preliminary FDA Communication on Gimoti NDA
    • Feb 26, 2019: Glenmark Pharmaceuticals announces results from new analysis of pooled data on Ryaltris, an investigational product for the treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting
    • Feb 25, 2019: Insys Therapeutics presented poster of initial pharmacokinetic study of epinephrine nasal spray for the emergency treatment of allergic reactions (type I) including anaphylaxis at American Academy of Allergy, Asthma and Immunology Annual Meeting
    • Feb 20, 2019: Indivior announces launch of SUBOXONE (buprenorphine and naloxone) sublingual film authorized generic
    • Feb 20, 2019: Alvogen Launches Generic Equivalent to Suboxone (buprenorphine/naloxone) Sublingual Film
    • Feb 20, 2019: Dr. Reddy's Laboratories announces the re-launch of its Buprenorphine and Naloxone Sublingual Film after favorable ruling in patent litigation
    • Feb 20, 2019: Neurelis announces that Intravail Licensee ARS Pharmaceuticals Intranasal Epinephrine program given Fast Track Designation
    • Feb 19, 2019: Optinose announces issuance of four additional U.S. patents covering XHANCE
    • Feb 19, 2019: ARS Pharmaceuticals announces FDA Fast Track Designation for ARS-1 Intranasal Epinephrine Spray
    • Feb 19, 2019: Impel NeuroPharma names Jennifer L. Berman as vice president of marketing
    • Feb 15, 2019: Optinose to highlight data at the 2019 AAAAI Annual Meeting in San Francisco
    • Feb 14, 2019: IntelGenx announces Montreal's Douglas Mental Health University Institute as ninth Montelukast VersaFilm phase 2a clinical trial site
    • Feb 13, 2019: Mithra successfully produces its first commercial batch of Myring for Europe
    • Feb 12, 2019: FDA Advisory Committee recommends approval of SPRAVATO (esketamine) Nasal Spray CIII for adults with treatment-resistant depression
    • Feb 12, 2019: Researchers at Queen's University Belfast have developed a vaginal ring capable of providing sustained delivery of OB-002 (5P12-RANTES) for HIV prevention
    • Feb 12, 2019: Generex Biotechnology names Marshal Schictman, Esq. as Executive Vice President General Counsel and Corporate SEC Attorney
    • Feb 05, 2019: Aquestive Therapeutics provides update regarding Suboxone sublingual film litigation
    • Feb 05, 2019: Dare Bioscience to Present at the 2019 BIO CEO & Investor Conference
    • Feb 04, 2019: BioDelivery announces expanded preferred insurance coverage for BELBUCA
    • Jan 30, 2019: Novus Therapeutics Advances OP0201 Development Program Across Several Clinical Trials
    • Jan 30, 2019: Sunovion receives complete response letter from FDA for Apomorphine sublingual film (APL-130277)
    • Jan 29, 2019: Orion Biotechnology Canada report that IND- enabling studies evaluating the safety of their OB 002H microbicide gel have shown an excellent mucosal safety profile
    • Jan 28, 2019: Dr. Reddy's Laboratories and its U.S. subsidiary, Promius Pharma, announce FDA approval for TOSYMRATM (sumatriptan nasal spray) 10 mg, in the U.S. market
    • Jan 23, 2019: IntelGenx Provides Update on Phase 2a Montelukast VersaFilm Clinical Trial
    • Jan 23, 2019: Ology Bioservices appoints vaccines and biologics manufacturing industry veteran, Brandon Brega, as chief operating officer
    • Jan 17, 2019: Medlab receives formal SME qualification from European Medicines Agency
    • Jan 15, 2019: BioDelivery Sciences International names Terry Coelho as chief financial officer
    • Jan 09, 2019: INSYS Therapeutics announces results of dose-finding PK study for Epinephrine Nasal Spray for treatment of anaphylaxis
    • Jan 08, 2019: Novus Therapeutics Doses First Patient with Acute Otitis Media in Phase 1 Study of OP0201
    • Jan 07, 2019: Evoke Pharma signs commercial and financial agreement for its lead product Gimoti in the U.S. with Novos Growth Partners
    • Jan 07, 2019: Generex Biotechnology CEO Joe Moscato Attending J.P. Morgan Healthcare Conference
    • Jan 03, 2019: Aquestive Therapeutics names Gary H. Slatko chief medical officer
    • Dec 24, 2018: Opiant Pharmaceuticals announces FDA Orange Book Listing for the new NARCAN Nasal Spray patent
    • Dec 17, 2018: INSYS Therapeutics provides updates on strategic alterative review process and its pipeline product Naloxone
    • Dec 17, 2018: INSYS Therapeutics provides update on Epinephrine nasal spray for anaphylaxis
    • Dec 17, 2018: Mylan adds first generic for Canasa rectal suppository to growing gastroenterology portfolio
    • Dec 17, 2018: INSYS Therapeutics Provides Update on Strategic Alterative Review Process and Product Pipeline Spanning Pharmaceutical Cannabinoids and Spray Technology
    • Dec 14, 2018: Mithra announces Myring update
    • Dec 14, 2018: Sonoma Pharmaceuticals announces management changes
    • Dec 12, 2018: BioXcel Therapeutics announces FDA acceptance of IND for lead neuroscience candidate, BXCL501 for the acute treatment of Agitation
    • Dec 10, 2018: Optinose announces first patient enrolled in clinical trial of XHANCE for Chronic Sinusitis
    • Dec 04, 2018: Consort Medical delivers profit growth in the first half
    • Nov 27, 2018: IntelGenx begins Montelukast VersaFilm dosing in patients with mild to moderate Alzheimer's disease in phase 2a study
    • Nov 21, 2018: Donna Lynne appointed to key leadership role at Columbia University Irving Medical Center
    • Nov 20, 2018: Dr. Reddy's Laboratories announces favorable outcome in Buprenorphine and Naloxone Sublingual Film patent litigation
    • Nov 16, 2018: Karo Pharma: Marketing territory for Viruseptin extended to include Denmark
    • Nov 15, 2018: Generex announces appointment of executive management team
    • Nov 14, 2018: BioXcel Therapeutics reports positive results from study in agitated schizophrenia patients supporting BXCL501 clinical development
    • Nov 13, 2018: ZolpiMist insomnia product development market update
    • Nov 13, 2018: Daré Bioscience provides business update and announces third quarter financial results
    • Nov 12, 2018: Privo Technologies Receives A $3M Award
    • Nov 10, 2018: Sonoma Pharmaceuticals' settlement of litigation against Collidion
    • Nov 08, 2018: Sonoma Pharmaceuticals reports record revenue in second quarter FY 2019
    • Nov 07, 2018: Impel NeuroPharma names Ellen A. Lubman as chief business officer
    • Nov 06, 2018: UDG Healthcare: Director declaration 2018
    • Nov 06, 2018: Consort Medical announces its board change
    • Nov 02, 2018: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency's approval of Dsuvia and the FDA's future consideration of new opioids
    • Nov 02, 2018: Acelrx Pharmaceuticals reports third quarter 2018 financial results and provides corporate update
    • Nov 01, 2018: INSYS Therapeutics announces results of PK study assessing proprietary intranasal Naloxone formulations versus intramuscular and intravenous Naloxone for Opioid Overdose
    • Oct 31, 2018: Scientus Pharma Provides Update on Buccal Cannabis Development Program
    • Oct 30, 2018: Dare Bioscience to present preclinical data of DARE-HRT1 intravaginal ring at AAPS 2018 meeting
    • Oct 30, 2018: Dare Bioscience to present preclinical data of DARE-FRT1 intravaginal ring at AAPS 2018 meeting
    • Oct 30, 2018: BioXcel Therapeutics provides update on the clinical advancement of BXCL501 for the acute treatment of agitation
    • Oct 25, 2018: Aquestive Therapeutics Announces Completion of Diazepam Buccal Film Adult Epilepsy Monitoring Unit (EMU) Clinical Study with Positive Topline Results
    • Oct 24, 2018: Emergent BioSolutions to offer all public libraries and YMCAs in the U.S. free opioid awareness education and NARCAN (naloxone HCl) Nasal Spray
    • Oct 24, 2018: Clinical trial expected to yield promising results for oral cancer patients
    • Oct 22, 2018: Opiant Pharmaceuticals to Participate in Opioid Panel at the BARDA Industry Day
    • Oct 19, 2018: AcelRx provides updated comments following positive FDA advisory committee meeting
    • Oct 17, 2018: Ology Bioservices Strengthens Management Team with Addition of Timothy Cooke, Ph.D. as Senior Vice President of Commercial Business
    • Oct 15, 2018: Avadel Pharmaceuticals presents data for NOCTIVA at 2018 American Urogynecologic Society Annual Scientific Meeting
    • Oct 12, 2018: AcelRx Pharmaceuticals: FDA Advisory Committee to Review DSUVIA New Drug Application
    • Oct 12, 2018: AcelRx Pharmaceuticals Stock Trading Halted
    • Oct 12, 2018: Generex announces Anthony S. Crisci, Esq., CPA as general manager, chief compliance officer and corporate counsel of its new, wholly-owned subsidiary, NuGenerex distribution solutions
    • Oct 10, 2018: Janssen submits European marketing authorisation application for Esketamine nasal spray for treatment-resistant depression
    • Oct 08, 2018: Lyra Therapeutics Presents Clinical Data For LYR-210 For Treatment Of Chronic Rhinosinusitis At The American Rhinologic Society Annual Meeting
    • Oct 04, 2018: MetP Pharma introduces Nascum-Plus Against the onset of air pollutioninduced inflammation
    • Oct 03, 2018: Optinose to highlight data at two upcoming scientific meetings
    • Sep 28, 2018: Avadel Pharmaceuticals announces Journal of Urology Publication of phase 3 data on NOCTIVA
    • Sep 25, 2018: Neurelis files new drug application with the FDA for VALTOCO (diazepam nasal spray), an investigational treatment for pediatric, adolescent and adult epilepsy patients
    • Sep 25, 2018: Patient recruitment to commence in Intelgenx's phase 2a Montelukast Versafilm trial in mild to moderate Alzheimer's disease
    • Sep 21, 2018: Janssen announces results of Esketamine nasal spray phase 3 study in patients with treatment-resistant depression
    • Sep 20, 2018: TherapeuticsMD Announces the FDA has Granted Annovera Marketing Exclusivity as a New Chemical Entity
    • Sep 20, 2018: Opiant Pharmaceuticals announces contract with Biomedical Advanced Research and Development Authority for up to $4.6 Million to accelerate development of OPNT003, nasal Nalmefene, for treatment of opioid overdose
    • Sep 19, 2018: Sonoma Pharmaceuticals names Phillipe Weigerstorfer as Board Director
    • Sep 18, 2018: Inova Personalized Health Accelerator Expands Precision Medicine Portfolio with Cyrano Therapeutics Novel Solution for Olfactory Impairment
    • Sep 17, 2018: Lyra Therapeutics to Present Clinical Data from Phase 1 Study of LYR-210 for the Treatment of Chronic Rhinosinusitis
    • Sep 17, 2018: Dare Bioscience names Greg Matz as board director
    • Sep 12, 2018: Biohaven announces submission of IND for BHV-3500, third-Generation, Small Molecule CGRP-receptor antagonist for the treatment of Migraine
    • Sep 11, 2018: AcelRx announces date of FDA Advisory Committee meeting for DSUVIA
    • Sep 10, 2018: Opiant Pharmaceuticals and Consort Medical announce manufacturing agreement for OPNT003, intranasal Nalmefene, for treatment of opioid overdose
    • Sep 04, 2018: Janssen Submits Esketamine Nasal Spray New Drug Application to U.S. FDA for treatment-resistant depression
    • Sep 04, 2018: Opiant Pharmaceuticals announces final patient enrolled in phase 2 clinical trial evaluating OPTN001 in bulimia nervosa
    • Sep 04, 2018: EyeGate announces top-line results for phase 3 trial of EGP-437 in anterior uveitis
    • Aug 30, 2018: FDA Grants INSYS Therapeutics Fast Track Designation for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis
    • Aug 29, 2018: New data on NOCTIVA presented at the 2018 International Continence Society Meeting
    • Aug 24, 2018: Mayne Pharma reports FY 18 result s underpinned by a significantly stronger second half
    • Aug 16, 2018: Evoke Pharma's Gimoti NDA Accepted for FDA Review
    • Aug 15, 2018: BioDelivery Sciences secures significant expanded preferred coverage for BELBUCA
    • Aug 13, 2018: Annovera contraceptive device gets US regulatory nod
    • Aug 13, 2018: FDA accepts New Drug Application to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters
    • Aug 13, 2018: Aytu BioScience announces accelerated launch of ZolpiMist in the U.S.
    • Aug 09, 2018: BioDelivery Sciences reports strong second quarter 2018 financial results
    • Aug 09, 2018: Corium International announces third quarter fiscal 2018 financial results
    • Aug 08, 2018: Sonoma Pharmaceuticals reports first quarter fy 2019 financial results
    • Aug 07, 2018: Vienna-based biotech company Marinomed obtains EU-wide certification for new cold medication
    • Aug 07, 2018: Epistatus 10 Mg (In 1 Ml) oromucosal solution Midazolam available on Nhs prescription is approved for use by both the Scottish Medicines Consortium (Smc) and the All Wales Medicines Strategy Group (Awmsg)
    • Aug 07, 2018: Glenmark Pharmaceuticals announces FDA acceptance of the company's first new drug application for Ryaltris for patients with seasonal allergic rhinitis
    • Aug 02, 2018: AcelRx Pharmaceuticals reports second quarter 2018 financial results
    • Jul 31, 2018: Marinomed Biotech names Pascal Schmidt as CFO
    • Jul 30, 2018: BioDelivery Sciences appoints Thomas Smith, MD as chief medical officer further expanding company's expertise in field of pain management
    • Jul 26, 2018: Cosmo Half-Year report 2018
    • Jul 23, 2018: Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus
    • Jul 20, 2018: Mithra obtains first Marketing Authorization for Myring in Europe
    • Jul 17, 2018: Orion Biotechnology awarded a $2M grant from National Center for Research and Development to fund further development of its HIV microbicide
    • Jul 13, 2018: Indivior Is Granted Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film
    • Jun 27, 2018: AcelRx receives European Commission approval for DZUVEO
    • Jun 27, 2018: BioXcel Therapeutics reports positive results from phase 1b trial of intravenously-dosed Dexmedetomidine supporting BXCL501 development
    • Jun 26, 2018: Albertsons Companies Offers Increased Access to Naloxone
    • Jun 25, 2018: Opiant Pharmaceuticals announces receipt of first tranche from National Institutes of Health Grant for development of OPNT003, intranasal Nalmefene, for treatment of opioid overdose
    • Jun 25, 2018: Generex Names Terry Thompson As Chief Operating Officer
    • Jun 21, 2018: Optinose Announces Publication of Pivotal Efficacy and Long-Term Safety Data for XHANCE in Peer Reviewed Journals
    • Jun 19, 2018: Novus Therapeutics Receives FDA Guidance at Type C Meeting for OP-02 in the Treatment and Prevention of Otitis Media
    • Jun 15, 2018: Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
    • Jun 14, 2018: Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Intramuscular Injection
    • Jun 14, 2018: Consort Medical delivered another year of good growth in revenue and profit
    • Jun 13, 2018: Sonoma Pharmaceuticals Announces Fiscal Year And Fourth Quarter 2018 Financial Results
    • Jun 06, 2018: Dare Bioscience Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Officer
    • Jun 04, 2018: Dare Bioscience Appoints Mary Jarosz To Global Head Of Regulatory Affairs
    • Jun 04, 2018: RDD Pharma Names Dr. Mark Sirgo As Chairman Of The Board Of Directors
    • May 29, 2018: Egalet Announces Large Regional Plan to Cover SPRIX Nasal Spray
    • May 29, 2018: ADAPT Pharma Launches New Online Platform for NARCAN
    • May 24, 2018: AcelRx announces FDA acceptance of NDA for DSUVIA
    • May 21, 2018: Summit Medical Group Research Aids in FDA Approval of Drug for Nasal Polyps
    • May 21, 2018: Glenmark Pharmaceuticals announces the company's first new drug application for Ryaltris for patients with seasonal allergic rhinitis
    • May 18, 2018: Avadel to Present Late-Breaker Data and Product Theater Forum at the 2018 American Urological Association Annual Meeting
    • May 15, 2018: Dare Bioscience Announces Trial Initiation for Ovaprene Non-Hormonal Monthly Contraceptive Candidate
    • May 14, 2018: Indivior Enters into Settlement with Par Pharmaceutical in Patent Infringement Case
    • May 14, 2018: Corium Announces Second Quarter Fiscal 2018 Financial Results
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook